Risk factors and risk prediction model for mucocutaneous separation in enterostomy patients: A single center experience

Table 1 Clinicopathological characteristics, n (%)

Variable	Non-MCS (n = 382)	MCS (n = 110)	P value
Sex			0.4106
Male	241 (63.1)	64 (58.2)
Female	141 (36.9)	46 (41.8)
Age (years)
< 60	115 (30.1)	35 (31.8)	0.8209
≥ 60	267 (69.9)	75 (68.25)
Intestinal rapture	14 (3.7)	12 (10.95)	0.0059
Diabetic	89 (23.3)	26 (23.6)	1.0000
Immunotherapy	153 (40.0)	45 (40.9)	0.9592
Neoadjuvant therapy	153 (40.0)	56 (50.9)	0.0548
Suture dislodgement	42 (11.0)	63 (57.3)	< 0.0001
Incision infection	49 (12.8)	42 (38.2)	< 0.0001
BMI (kg/m2)
< 24	257 (67.3)	54 (49.1)	0.0007
≥ 24	125 (32.7)	56 (50.9)
Stoma site
Ileum	228 (59.7)	83 (75.4)	0.0036
Colon	154 (40.3)	27 (24.6)
Elevated intra-abdominal pressure	183 (47.9)	65 (59.1)	0.0501
Hemoglobin level
≤ 90	82 (21.5)	34 (30.9)	0.0501
> 90	300 (78.5)	76 (69.1)
Albumin level
≤ 28	54 (14.1)	34 (30.9)	< 0.0001
> 28	328 (85.9)	76 (69.1)

BMI: Body mass index; MCS: Mucocutaneous separation.